North China Pharmaceutical Company.Ltd (SHA:600812)

SHA:600812 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	161.04	183.06	126.99	4.89	-689.23	18.73
Depreciation & Amortization	940.14	940.14	863.4	878.05	779.02	703.23
Other Amortization	19.54	19.54	12.01	10.79	10.41	8.68
Loss (Gain) From Sale of Assets	-0.83	-0.83	-0.44	-0.76	-0.44	-3.4
Asset Writedown & Restructuring Costs	0.76	0.76	4.73	0.05	0.24	-
Loss (Gain) From Sale of Investments	-60.63	-60.63	-46.16	-46.85	-44.02	-39.12
Provision & Write-off of Bad Debts	44.29	44.29	41.5	10.56	44.94	22.77
Other Operating Activities	435.23	417.86	539.63	550.93	1,404	641.66
Change in Accounts Receivable	-197.85	-197.85	377.13	342.83	-578.35	-329.25
Change in Inventory	118.9	118.9	94.32	-87.11	-191.92	86.61
Change in Accounts Payable	-283.44	-283.44	-792.32	-637.27	275.22	-58.2
Operating Cash Flow	1,172	1,177	1,230	1,024	1,004	1,050
Operating Cash Flow Growth	41.91%	-4.31%	20.04%	1.98%	-4.37%	39.63%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-544.22	-542.01	-784.22	-623.04	-549.58	-547.5
Sale of Property, Plant & Equipment	0.65	0.62	1.27	0.69	22.26	6.54
Cash Acquisitions	-	-	-674.26	-	-	-
Investment in Securities	-300	-300	-0.24	-260	-2	-240
Other Investing Activities	0.47	60.47	510.72	0.59	0.86	1.69
Investing Cash Flow	-843.1	-780.93	-946.73	-881.75	-528.46	-779.26

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	1,380	190	410	623.2	824.12
Long-Term Debt Issued	-	8,778	10,226	9,995	10,270	10,251
Total Debt Issued	12,615	10,158	10,416	10,405	10,893	11,075
Short-Term Debt Repaid	-	-1,160	-404.1	-841.27	-1,178	-440
Long-Term Debt Repaid	-	-9,408	-9,947	-9,904	-13,493	-9,754
Total Debt Repaid	-13,264	-10,568	-10,351	-10,746	-14,671	-10,194
Net Debt Issued (Repaid)	-649.16	-410.59	65.15	-340.33	-3,778	881.37
Issuance of Common Stock	5	5	3	10	5.94	-
Common Dividends Paid	-414.37	-412.84	-469.07	-498.58	-741.6	-746.79
Other Financing Activities	323.32	433.17	863.66	124.77	35.05	180
Financing Cash Flow	-735.22	-385.26	462.74	-704.14	-4,479	314.58

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-7.96	0.48	11.83	12.07	8.44	-3.13
Net Cash Flow	-414.39	10.82	757.4	-549.56	-3,994	582.42

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	627.68	634.53	445.35	401.23	454.81	502.75
Free Cash Flow Growth	452.18%	42.48%	11.00%	-11.78%	-9.54%	-
Free Cash Flow Margin	7.12%	6.87%	4.51%	3.96%	4.33%	4.84%
Free Cash Flow Per Share	0.37	0.37	0.26	0.25	0.27	0.29
Levered Free Cash Flow	159.59	543.9	379.66	156.09	181.33	-902.49
Unlevered Free Cash Flow	371.55	769.87	666.35	469.77	555.95	-500.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	388.92	344.58	389.03	506.93	416.57	470.37
Change in Working Capital	-367.66	-367.66	-312.09	-383.39	-500.29	-302.32

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error